Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -2.41x is 77% above its 5-year average of -10.49x, near the high end of its 5-year range (-111.20x–4.56x).
As of the fiscal period ended Saturday, September 30, 2023. 48.90% above its 12-month average of -4.73x.
Reported quarterly interest coverage; no daily interpolation. Q3 FY2023 (2023-09-30): -2.41x.
INTEREST COVERAGE RATIO
-2.41x
INTEREST COVERAGE RATIO AVG TTM
-4.73x
INTEREST COVERAGE RATIO AVG 3Y
-19.48x
INTEREST COVERAGE RATIO AVG 5Y
-10.49x
INTEREST COVERAGE RATIO AVG 10Y
-17.55x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+48.90%
CURRENT VS 3Y AVG
+87.60%
CURRENT VS 5Y AVG
+76.98%
CURRENT VS 10Y AVG
+86.24%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.20x
median of 329 covered companies
CURRENT VS SECTOR MEDIAN
+42.51%
vs the sector median at left
Avalo Therapeutics, Inc.
Market Cap
$766.41M
Interest Coverage Ratio
-2.41x
TTM Avg
-4.73x
3Y Avg
-19.48x
5Y Avg
-10.49x
Market Cap
$774.54M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$775.72M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$776.24M
Interest Coverage Ratio
-1.65x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$785.03M
Interest Coverage Ratio
1.76x
TTM Avg
1.92x
3Y Avg
1.86x
5Y Avg
1.93x
Market Cap
$756.15M
Interest Coverage Ratio
-22.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$786.48M
Interest Coverage Ratio
-85.20x
TTM Avg
23.14x
3Y Avg
23.14x
5Y Avg
23.14x
Market Cap
$737.02M
Interest Coverage Ratio
-1286.22x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avalo Therapeutics, Inc. (AVTX) | $766.41M | -2.41x | -4.73x | -19.48x | -10.49x |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.54M | N/A | N/A | N/A | N/A |
| Design Therapeutics, Inc. (DSGN)vs › | $775.72M | N/A | N/A | N/A | N/A |
| Geron Corporation (GERN)vs › | $776.24M | -1.65x | N/A | N/A | N/A |
| AdaptHealth Corp. (AHCO)vs › | $785.03M | 1.76x | 1.92x | 1.86x | 1.93x |
| Candel Therapeutics, Inc. (CADL)vs › | $756.15M | -22.78x | N/A | N/A | N/A |
| Cytek Biosciences, Inc. (CTKB)vs › | $786.48M | -85.20x | 23.14x | 23.14x | 23.14x |
| Anteris Technologies Global Corp. (AVR)vs › | $737.02M | -1286.22x | N/A | N/A | N/A |
| InMode Ltd. (INMD)vs › | $812.20M | N/A | N/A | N/A | N/A |
| Achieve Life Sciences, Inc. (ACHV)vs › | $724.77M | -67.01x | 15.61x | 8.76x | 6.40x |
Interest Coverage
-2.4x
Debt/Equity
0.00
Current Ratio
19.31
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-09-30 | -2.41x |
| 2023-06-30 | -7.18x |
| 2023-03-31 | -9.26x |
| 2022-12-31 | -9.33x |
| 2022-09-30 | 4.56x |
| 2022-06-30 | -10.25x |
| 2022-03-31 | -17.84x |
| 2021-12-31 | -15.17x |
| 2021-09-30 | -16.71x |
| 2021-06-30 | -111.20x |
| 2019-12-31 | 0.78x |
| 2019-09-30 | -18.04x |
| 2018-12-31 | -25.02x |
| 2018-09-30 | -103.16x |
| 2018-06-30 | -23.68x |
| 2018-03-31 | -34.78x |
| 2017-12-31 | -145.36x |
| 2017-09-30 | 745.95x |
| 2017-06-30 | -69.25x |
| 2017-03-31 | -32.89x |
| 2016-12-31 | -20.31x |
| 2016-09-30 | -57.24x |
| 2016-03-31 | -32.83x |
| 2015-12-31 | -23.20x |
| 2015-09-30 | -9.92x |
| 2015-06-30 | -13.21x |
| 2015-03-31 | -11.38x |
| 2014-12-31 | -17.23x |
| 2014-09-30 | -31.62x |
| 2014-06-30 | -4.60x |
| 2014-03-31 | -7623.30x |
